Yuko Ishihara

850 citations

38 papers · 380 indexed · h-index 13

Co-authors: Shinichi Kako Koji Kawamura Yoshinobu Kanda Kana Sakamoto Hideki Nakasone Misato Kikuchi Miki Sato Kiriko Terasako‐Saito
Topics: Hematopoietic Stem Cell Transplantation (15 papers)Neutropenia and Cancer Infections (10 papers)Lymphoma Diagnosis and Treatment (5 papers)
Cited by: Hematology Clinical Biochemistry Transplantation
Journals: PLoS ONE Scientific Reports Annals of Oncology
Partner nations: Japan Ireland India

In The Last Decade

Yuko Ishihara

36 papers receiving 377 citations

Peers

Countries citing papers authored by Yuko Ishihara

Since Specialization

Citations

This map shows the geographic impact of Yuko Ishihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Ishihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Ishihara more than expected).

Fields of papers citing papers by Yuko Ishihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Ishihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Ishihara. The network helps show where Yuko Ishihara may publish in the future.

Co-authorship network of co-authors of Yuko Ishihara

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Ishihara. A scholar is included among the top collaborators of Yuko Ishihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Ishihara. Yuko Ishihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P33-7 Two patients with DLBCL who developed aortitis following pegfilgrastim administration during chemoimmunotherapy 2023 ·Annals of Oncology ·(unknown),Hiroaki Asai,(unknown),(unknown),(unknown),(unknown),(unknown),Yuko Ishihara,Yuko Mishima,Dai Maruyama	0
2	Dose-escalation part of Phase I study of single-agent mosunetuzumab in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma 2023 ·Japanese Journal of Clinical Oncology ·Wataru Munakata,Koji Izutsu,Yuko Mishima,Hirokazu Nagai,Yuko Ishihara,Junji Suzumiya,Yuzuru Kanakura,Toshihiro Nanki,(unknown),(unknown),(unknown),Kenichi Ishizawa	2
3	Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia 2020 ·Biology of Blood and Marrow Transplantation ·Koji Kawamura,Yukië Tanaka,Hideki Nakasone,Yuko Ishihara,Shinichi Kako,Seiichiro Kobayashi,Yuetsu Tanaka,Tsukasa Ohmori,Kaoru Uchimaru,Sachiko Okamoto,Junichi Mineno,Hiroshi Shiku,Satoshi Nishimura,Yoshinobu Kanda	16
4	Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation 2018 ·Bone Marrow Transplantation ·J. Hayakawa,(unknown),Shun‐ichi Kimura,Ayumi Gomyo,Masaharu Tamaki,Yu Akahoshi,Naonori Harada,Tomotaka Ugai,Machiko Kusuda,Kazuaki Kameda,(unknown),Yuko Ishihara,Koji Kawamura,Kana Sakamoto,Miki Sato,Kiriko Terasako‐Saito,Misato Kikuchi,Hideki Nakasone,Shinichi Kako,Yoshinobu Kanda	17
5	Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan 2018 ·International Journal of Hematology ·Masaharu Tamaki,Hideki Nakasone,Ayumi Gomyo,J. Hayakawa,Yu Akahoshi,Naonori Harada,Machiko Kusuda,Yuko Ishihara,Koji Kawamura,Aki Tanihara,Miki Sato,Kiriko Terasako‐Saito,Kazuaki Kameda,(unknown),Misato Kikuchi,Shun‐ichi Kimura,Shinichi Kako,Yoshinobu Kanda	3
6	Outcome of gastrointestinal graft-versus-host disease according to the treatment response 2018 ·Annals of Hematology ·Masaharu Tamaki,Hideki Nakasone,(unknown),Kazuki Yoshimura,Ayumi Gomyo,J. Hayakawa,Machiko Kusuda,Yu Akahoshi,Yuko Ishihara,Koji Kawamura,Aki Tanihara,Miki Sato,Kiriko Terasako‐Saito,Kazuaki Kameda,Hidenori Wada,Misato Kikuchi,Shun‐ichi Kimura,Shinichi Kako,Yoshinobu Kanda	6
7	Pseudo-autologous stem cell transplantation for donor-derived mantle cell lymphoma 12 years after allogeneic transplantation 2017 ·International Journal of Hematology ·Masaharu Tamaki,Hidenori Wada,Ayumi Gomyo,J. Hayakawa,Yu Akahoshi,Naonori Harada,Machiko Kusuda,Yuko Ishihara,Koji Kawamura,Aki Tanihara,Miki Sato,Kiriko Terasako‐Saito,Kazuaki Kameda,Misato Kikuchi,Shun‐ichi Kimura,Hideki Nakasone,Shinichi Kako,(unknown)	1
8	Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia 2017 ·International Journal of Hematology ·J. Hayakawa,Junya Kanda,Yu Akahoshi,Naonori Harada,Kazuaki Kameda,Tomotaka Ugai,Hidenori Wada,Yuko Ishihara,Koji Kawamura,Kana Sakamoto,Masahiro Ashizawa,Miki Sato,Kiriko Terasako‐Saito,Shun‐ichi Kimura,Misato Kikuchi,Rie Yamazaki,Shinichi Kako,Yoshinobu Kanda	26
9	Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft‐versus‐host disease and survival outcome 2017 ·Hematological Oncology ·Yu Akahoshi,Shun‐ichi Kimura,Ayumi Gomyo,J. Hayakawa,Masaharu Tamaki,Naonori Harada,Machiko Kusuda,Kazuaki Kameda,Tomotaka Ugai,(unknown),Yuko Ishihara,Koji Kawamura,Kana Sakamoto,Miki Sato,Kiriko Terasako‐Saito,Misato Kikuchi,Hideki Nakasone,Shinichi Kako,Yoshinobu Kanda	22
10	Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography 2017 ·Infectious Diseases ·Yu Akahoshi,Shun‐ichi Kimura,Ayumi Gomyo,J. Hayakawa,Masaharu Tamaki,Naonori Harada,Machiko Kusuda,Kazuaki Kameda,Tomotaka Ugai,(unknown),Yuko Ishihara,Koji Kawamura,Kana Sakamoto,Miki Sato,Kiriko Terasako‐Saito,Misato Kikuchi,Hideki Nakasone,Shinichi Kako,Yoshinobu Kanda	2
11	Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation 2016 ·Biology of Blood and Marrow Transplantation ·Yu Akahoshi,Junya Kanda,Ayumi Gomyo,J. Hayakawa,Yusuke Komiya,Naonori Harada,Kazuaki Kameda,Tomotaka Ugai,(unknown),Yuko Ishihara,Koji Kawamura,Kana Sakamoto,Miki Sato,Kiriko Terasako‐Saito,Shun‐ichi Kimura,Misato Kikuchi,Hideki Nakasone,Shinichi Kako,Yoshinobu Kanda	34
12	Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients 2016 ·Journal of Infection and Chemotherapy ·Shun‐ichi Kimura,Ayumi Gomyo,J. Hayakawa,Yu Akahoshi,Naonori Harada,Tomotaka Ugai,Yusuke Komiya,Kazuaki Kameda,Hidenori Wada,Yuko Ishihara,Koji Kawamura,Kana Sakamoto,Miki Sato,Kiriko Terasako‐Saito,Misato Kikuchi,Hideki Nakasone,Junya Kanda,Shinichi Kako,Aki Tanihara,Yoshinobu Kanda	17
13	Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding 2016 ·International Journal of Hematology ·Hirofumi Nakano,Masahiro Ashizawa,Yu Akahoshi,Tomotaka Ugai,Hidenori Wada,Ryoko Yamasaki,Yuko Ishihara,Koji Kawamura,Kana Sakamoto,Miki Sato,Kiriko Terasako‐Saito,Shun-ichi Kimura,Misato Kikuchi,Hideki Nakasone,Shinichi Kako,Junya Kanda,Rie Yamazaki,Aki Tanihara,Junji Nishida,Yoshinobu Kanda	12
14	Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia 2014 ·International Journal of Hematology ·Yuko Ishihara,Junya Kanda,Kaori Tanaka,Hirofumi Nakano,Tomotaka Ugai,Hidenori Wada,Ryoko Yamasaki,Koji Kawamura,Kana Sakamoto,Masahiro Ashizawa,Miki Sato,Kiriko Terasako‐Saito,(unknown),Misato Kikuchi,Hideki Nakasone,Rie Yamazaki,Shinichi Kako,Junji Nishida,Kunitomo Watanabe,Yoshinobu Kanda	2
15	A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia 2014 ·International Journal of Hematology ·Masahiro Ashizawa,Yu Akahoshi,Hirofumi Nakano,Tomotaka Ugai,Hidenori Wada,Ryoko Yamasaki,Yuko Ishihara,Koji Kawamura,Kana Sakamoto,Miki Sato,Kiriko Terasako,Shun-ichi Kimura,Misato Kikuchi,Hideki Nakasone,Shinichi Kako,Junya Kanda,Rie Yamazaki,Aki Tanihara,Junji Nishida,Yoshinobu Kanda	5
16	Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation 2013 ·International Journal of Infectious Diseases ·Koji Kawamura,Hidenori Wada,Ryoko Yamasaki,Yuko Ishihara,Kana Sakamoto,Masahiro Ashizawa,Miki Sato,(unknown),Kiriko Terasako,Shun-ichi Kimura,Misato Kikuchi,Hideki Nakasone,Rie Yamazaki,Junya Kanda,Shinichi Kako,Aki Tanihara,Junji Nishida,Yoshinobu Kanda	27
17	Allotype Analysis to Distinguish the Origin of Varicella-Zoster Virus Immunoglobulin G after Allogeneic Stem Cell Transplantation 2013 ·Biology of Blood and Marrow Transplantation ·Rie Yamazaki,Hideki Nakasone,Yukië Tanaka,Miki Sato,Kiriko Terasako,Hidenori Wada,Yuko Ishihara,Koji Kawamura,Kana Sakamoto,Masahiro Ashizawa,(unknown),Shun-ichi Kimura,Misato Kikuchi,Shinya Okuda,Shinichi Kako,Junya Kanda,Aki Tanihara,Junji Nishida,Yoshinobu Kanda	1
18	Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies 2013 ·Transfusion and Apheresis Science ·Koji Kawamura,Misato Kikuchi,Kiriko Terasako,Hidenori Wada,Ryoko Yamasaki,Yuko Ishihara,Kana Sakamoto,Masahiro Ashizawa,Miki Sato,(unknown),Shun-ichi Kimura,Hideki Nakasone,Shinya Okuda,Rie Yamazaki,Junya Kanda,Shinichi Kako,Yukië Tanaka,Aki Tanihara,Junji Nishida,Yoshinobu Kanda	6
19	Evaluation of the Validity of Preemptive Therapy against Cytomegalovirus Disease Based on Antigenemia Assay with a Cutoff of 20 Positive Cells per Two Slides 2013 ·PLoS ONE ·Kana Sakamoto,Hideki Nakasone,Hidenori Wada,Ryoko Yamasaki,Yuko Ishihara,Koji Kawamura,Masahiro Ashizawa,Miki Sato,Kiriko Terasako‐Saito,(unknown),Shun-ichi Kimura,Misato Kikuchi,Shinichi Kako,Junya Kanda,Rie Yamazaki,Aki Tanihara,Junji Nishida,(unknown)	16
20	Long-Term Persistence of Limited HTLV-I Tax-specific Cytotoxic T Cell Clones in a Patient with Adult T Cell Leukemia/Lymphoma after Allogeneic Stem Cell Transplantation 2012 ·Journal of Clinical Immunology ·Yukië Tanaka,Hideki Nakasone,Rie Yamazaki,Hidenori Wada,Yuko Ishihara,Koji Kawamura,Kana Sakamoto,Masahiro Ashizawa,(unknown),Miki Sato,Kiriko Terasako,Shun-ichi Kimura,Misato Kikuchi,Shinya Okuda,Shinichi Kako,Junya Kanda,Aki Tanihara,Junji Nishida,Yoshinobu Kanda	14

About Yuko Ishihara

Yuko Ishihara is a scholar working on Hematology, Transplantation and Oncology, having authored 38 papers that have together received 380 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (15 papers), Neutropenia and Cancer Infections (10 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Hematology (208 citations), Clinical Biochemistry (36 citations) and Transplantation (14 citations). Yuko Ishihara has collaborated with scholars based in Japan, Ireland and India. Frequent co-authors include Shinichi Kako, Koji Kawamura, Yoshinobu Kanda, Kana Sakamoto, Hideki Nakasone, Misato Kikuchi, Miki Sato, Kiriko Terasako‐Saito, Junya Kanda and Tomotaka Ugai. Their work appears in journals such as PLoS ONE, Scientific Reports and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact